Phase I study of an oral histone deacetylase inhibitor, suberoylanilide hydroxamic acid, in patients with advanced cancer
(Q35758280)
scientific article published on 16 May 2005
scientific article published on 16 May 2005
Language:
Current Data About
Phase I study of an oral histone deacetylase inhibitor, suberoylanilide hydroxamic acid, in patients with advanced cancer